Astrid Suchy-Dicey1, Barbara Howard2, W T Longstreth3, Eric M Reiman4, Dedra Buchwald1. 1. Washington State University Elson S Floyd College of Medicine, Seattle, Washington, USA. 2. MedStar Health Research Institute, Phoenix, Arizona, USA. 3. University of Washington Neurology and Epidemiology Departments, Seattle, Washington, USA. 4. Banner Alzheimer's Institute, Phoenix, Arizona, USA.
Abstract
BACKGROUND: The apolipoprotein E (APOE) ε4 allele confers higher risk of neurodegeneration and Alzheimer's disease (AD), but differs by race/ethnicity. We examined this association in American Indians. METHODS: The Strong Heart Study is a population-based cohort of American Indians who were 64 to 95 years of age in 2010 to 2013. APOE ε4 status, brain imaging, and neuropsychological testing was collected in N = 811 individuals. Summary statistics, graphics, and generalized linear regressions-adjusted for sociodemographics, clinical features, and intracranial volume with bootstrap variance estimator-compared APOE ε4 carriers with non-carriers. RESULTS: APOE ε4 carriers comprised 22% of the population (0.7% homozygotes). Participants were mean 73 years, 67% female, and 54% had some college education. The majority were obese (>50%), hypertensive (>80%), and diabetic (>50%). Neither imaging findings nor multidomain cognitive testing showed any substantive differences between APOE ε4 carriers and non-carriers. CONCLUSION: We found no evidence of neurodegenerative risk from APOE ε4 in American Indians. Additional studies are needed to examine potential protective features.
BACKGROUND: The apolipoprotein E (APOE) ε4 allele confers higher risk of neurodegeneration and Alzheimer's disease (AD), but differs by race/ethnicity. We examined this association in American Indians. METHODS: The Strong Heart Study is a population-based cohort of American Indians who were 64 to 95 years of age in 2010 to 2013. APOE ε4 status, brain imaging, and neuropsychological testing was collected in N = 811 individuals. Summary statistics, graphics, and generalized linear regressions-adjusted for sociodemographics, clinical features, and intracranial volume with bootstrap variance estimator-compared APOE ε4 carriers with non-carriers. RESULTS: APOE ε4 carriers comprised 22% of the population (0.7% homozygotes). Participants were mean 73 years, 67% female, and 54% had some college education. The majority were obese (>50%), hypertensive (>80%), and diabetic (>50%). Neither imaging findings nor multidomain cognitive testing showed any substantive differences between APOE ε4 carriers and non-carriers. CONCLUSION: We found no evidence of neurodegenerative risk from APOE ε4 in American Indians. Additional studies are needed to examine potential protective features.
Authors: Fumiko Irie; Kamal H Masaki; Helen Petrovitch; Robert D Abbott; G Webster Ross; Dennis R Taaffe; Lenore J Launer; Lon R White Journal: Arch Gen Psychiatry Date: 2008-08
Authors: Gali H Weissberger; Daniel A Nation; Caroline P Nguyen; Mark W Bondi; S Duke Han Journal: Neurosci Biobehav Rev Date: 2018-08-17 Impact factor: 8.989
Authors: J T Shaw; J Tate; J B Kesting; M Marczak; J R Berkholz; P K Lovelock; D Purdie; P Hickman; D P Cameron Journal: Med J Aust Date: 1999-02-15 Impact factor: 7.738
Authors: D Galasko; D Salmon; A Gamst; J Olichney; L J Thal; L Silbert; J Kaye; P Brooks; R Adonay; U-K Craig; G Schellenberg; A R Borenstein Journal: Neurology Date: 2007-05-22 Impact factor: 9.910
Authors: Richard J Caselli; Blake T Langlais; Amylou C Dueck; Yinghua Chen; Yi Su; Dona E C Locke; Bryan K Woodruff; Eric M Reiman Journal: Alzheimers Dement Date: 2020-01-06 Impact factor: 21.566
Authors: Eric M Reiman; Joseph F Arboleda-Velasquez; Yakeel T Quiroz; Matthew J Huentelman; Thomas G Beach; Richard J Caselli; Yinghua Chen; Yi Su; Amanda J Myers; John Hardy; Jean Paul Vonsattel; Steven G Younkin; David A Bennett; Philip L De Jager; Eric B Larson; Paul K Crane; C Dirk Keene; M Ilyas Kamboh; Julia K Kofler; Linda Duque; John R Gilbert; Harry E Gwirtsman; Joseph D Buxbaum; Dennis W Dickson; Matthew P Frosch; Bernardino F Ghetti; Kathryn L Lunetta; Li-San Wang; Bradley T Hyman; Walter A Kukull; Tatiana Foroud; Jonathan L Haines; Richard P Mayeux; Margaret A Pericak-Vance; Julie A Schneider; John Q Trojanowski; Lindsay A Farrer; Gerard D Schellenberg; Gary W Beecham; Thomas J Montine; Gyungah R Jun Journal: Nat Commun Date: 2020-02-03 Impact factor: 17.694